Respiratory Distress Syndrome, Newborn Clinical Trials

7 recruitingLast updated: May 13, 2026

There are 7 actively recruiting respiratory distress syndrome, newborn clinical trials across 6 countries. Studies span Not Applicable, Phase 4. Top locations include Ankara, Sihhiye, Turkey (Türkiye), Doha, Qatar, Edinburgh, United Kingdom. Updated daily from ClinicalTrials.gov.


Respiratory Distress Syndrome, Newborn Trials at a Glance

7 actively recruiting trials for respiratory distress syndrome, newborn are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Ankara, Doha, and Edinburgh. Lead sponsors running respiratory distress syndrome, newborn studies include Endeavor Health, Hamad General Hospital, and Connecticut Children's Medical Center.

Browse respiratory distress syndrome, newborn trials by phase

About Respiratory Distress Syndrome, Newborn Clinical Trials

Looking for clinical trials for Respiratory Distress Syndrome, Newborn? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Respiratory Distress Syndrome, Newborn trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Respiratory Distress Syndrome, Newborn clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Optimising Breathing Support at Extubation in Very Preterm Infants: A Clinical Study

Respiratory Distress Syndrome in Premature InfantRespiratory Distress Syndrome, Newborn
Murdoch Childrens Research Institute134 enrolled2 locationsNCT07251790
Recruiting
Not Applicable

LISA vs Endotracheal Surfactant in Preterm Neonates: A Lung Ultrasound Distribution Study

Respiratory Distress Syndrome, Newborn
Hamad General Hospital22 enrolled1 locationNCT07514481
Recruiting
Not Applicable

Evaluation of Serial Lung Ultrasound Data After Surfactant Treatments Applied With Different Methods in Preterm Babies

Respiratory Distress Syndrome, NewbornNewborn Complication
Konya City Hospital68 enrolled1 locationNCT06880016
Recruiting

Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting

Transient Tachypnea of the NewbornPneumothoraxRespiratory Distress Syndrome in Premature Infant+5 more
Mayo Clinic500 enrolled1 locationNCT07344714
Recruiting
Phase 4

Prophylactic Minimally Invasive Surfactant Evaluation

Premature BirthRespiratory Distress Syndrome, Newborn
Endeavor Health200 enrolled1 locationNCT06007547
Recruiting
Not Applicable

Echography-guided Surfactant THERapy (ESTHER) For Preterm Infants With Respiratory Failure

Intensive Care Units, NeonatalRespiratory Distress Syndrome, NewbornPulmonary Surfactants
Connecticut Children's Medical Center52 enrolled1 locationNCT06446453
Recruiting

European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank

Lung Diseases, InterstitialPulmonary FibrosisChild+3 more
Matthias Griese1,000 enrolled3 locationsNCT02852928